✦ LIBER ✦

Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8–10 cancers

✍ Scribed by Stephen A. Boorjian; R. Jeffrey Karnes; Laureano J. Rangel; Eric J. Bergstralh; Igor Frank; Michael L. Blute

Book ID: 109053637
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 158 KB
Volume: 101
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2007.07269.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and pathologic outcome after ra

Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10

✍ Patrick J. Bastian; Mark L. Gonzalgo; William J. Aronson; Martha K. Terris; Chri 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

Radical prostatectomy for clinically adv

Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome

✍ John F. Ward; Jeffrey M. Slezak; Michael L. Blute; Erik J. Bergstralh; Horst Zin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Pathologic findings and prostate specifi

Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a Gleason score ≤ 7

✍ Anthony V. D'Amico; Yuehui Wu; Ming-Hui Chen; Marc Nash; Andrew A. Renshaw; Jero 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

Obesity and oncological outcome after ra

Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center Databases

✍ Stephen J. Freedland; Leon Sun; Christopher J. Kane; Joseph C. Presti Jr; Martha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Clinical utility of antioxidant gene exp

Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4–10 ng/mL and disease prognostication after radical prostatectomy

✍ Michael Giesing; Bernhard Suchy; Gerhard Driesel; Dietmar Molitor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB

Incidence of positive pelvic lymph nodes

Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of ≤10 ng/mL and biopsy Gleason score of ≤6, and their influence on PSA progression-free survival after radical prostatectomy

✍ DOROTHEA WECKERMANN; MARCUS GOPPELT; ROBERT DORN; FRIEDHELM WAWROSCHEK; ROLF HAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB